名稱 | BRCA2 p.E2292A Reference Standard 標(biāo)準(zhǔn)品 |
型號(hào) | CBP10566 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BRCA2 p.E2292A Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 購(gòu)買細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn):ADORA2B(腺苷A2B受體)
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 探討腫瘤細(xì)胞的“冷與熱”之分
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- NCRI:新型檢測(cè)技術(shù)或能提前8年診斷出食管癌
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10566BRCA2 p.E2292A Reference Standard 標(biāo)準(zhǔn)品

- 詳細(xì)內(nèi)容
Format | Genomic DNA |
Description | BRCA2, breast cancer type 2 susceptibility protein, is a tumor suppressor involved in the homologous recombination pathway for double-strand DNA repair, thereby playing a role in genome stability. BRCA2 germline mutations increase the risk of developing ovarian and/or breast cancer and somatic mutations are highest in colon, NSCLC, and ovarian cancers. |
Technical Data | |
DNA Change | c.6875A>C |
AA Change | p.E2292A |
Zygosity | Heterozygous |
Allelic Frequency | 75% |
Transcript | NM_000059.4 |
Cosmic ID | N/A |
Chr position(GRCh37) | chr13:32918728 |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | ![]() |
Storage | 4°C |
Expiry | 36 months from the date of manufacture |